SENORES
Invest with MTF
Invest Now
Invest in Senores Pharmaceuticals with 3.01X leverage
Performance
- Low
- ₹746
- High
- ₹783
- 52 Week Low
- ₹435
- 52 Week High
- ₹832
- Open Price₹778
- Previous Close₹777
- Volume184,557
Investment Returns
- Over 1 Month -8.54%
- Over 3 Month + 4.66%
- Over 6 Month + 41.24%
- Over 1 Year + 92.49%
Smart Investing Starts Here Start SIP with Senores Pharmaceuticals for Steady Growth!
Senores Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 39.8
- PEG Ratio
- 0.6
- Market Cap Cr
- 3,466
- P/B Ratio
- Average True Range
- 28.1
- EPS
- 18.92
- Dividend Yield
- 0
- MACD Signal
- 9.54
- RSI
- 43
- MFI
- 47.18
Senores Pharmaceuticals Financials
Senores Pharmaceuticals Technicals
EMA & SMA
Current Price
₹752.65
-24.1
(-3.1%)
- Bearish Moving Average 11
- Bullish Moving Average 5
- 20 Day
- ₹783.95
- 50 Day
- ₹762.12
- 100 Day
- ₹720.72
- 200 Day
- ₹647.22
Resistance and Support
760.65
- R3 811.40
- R2 797.15
- R1 774.90
- S1 738.40
- S2 724.15
- S3 701.90
Senores Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-06 | Quarterly Results | |
| 2025-07-23 | Quarterly Results & Others | To consider other business matters. |
| 2025-05-15 | Audited Results | |
| 2025-01-23 | Quarterly Results & Others | To consider other business matters. |
Senores Pharmaceuticals F&O
About Senores Pharmaceuticals
- NSE Symbol
- SENORES
- BSE Symbol
- 544319
- Managing Director
- Mr. Swapnil Jatinbhai Shah
- ISIN
- INE0RB801010
Similar Stocks to Senores Pharmaceuticals
Senores Pharmaceuticals FAQs
Senores Pharmaceuticals share price is ₹752 As on 09 December, 2025 | 03:53
The Market Cap of Senores Pharmaceuticals is ₹3466.2 Cr As on 09 December, 2025 | 03:53
The P/E ratio of Senores Pharmaceuticals is 39.8 As on 09 December, 2025 | 03:53
The PB ratio of Senores Pharmaceuticals is 4.4 As on 09 December, 2025 | 03:53
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.